Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study (Q36512029)

14 August 2017

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study (English)

1 reference

14 August 2017

1 reference

J N Pande

1

1 reference

14 August 2017

S P Singh

2

1 reference

14 August 2017

G C Khilnani

3

1 reference

14 August 2017

S Khilnani

4

1 reference

14 August 2017

R K Tandon

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

14 August 2017

1 reference

14 August 2017

51

1 reference

14 August 2017

132-136

1 reference

14 August 2017

2

1 reference

14 August 2017

Tuberculosis and poverty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Malnutrition and drugs: clinical implications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Drug treatment of tuberculosis--1992

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Sulphadimidine Acetylation Test for Classification of Patients as Slow or Rapid Inactivators of Isoniazid

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Isoniazid-rifampin-induced hepatitis in hepatitis B carriers

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Hepatitis cases in isoniazid treated groups and in a control group

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473016

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

28 June 2018

1 reference

12 December 2020

Isoniazid preventive therapy: Retrospect and prospect

1 reference

12 December 2020

Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis

1 reference

12 December 2020

Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial

1 reference

12 December 2020

Hepatotoxicity of isoniazid and rifampin in children

1 reference

12 December 2020

Isoniazid, rifampin, and hepatotoxicity

1 reference

12 December 2020

Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide

1 reference

12 December 2020

Study on hepatotoxicity and other side-effects of antituberculosis drugs

1 reference

12 December 2020

Hepatotoxicity of rifampin and isoniazid. Is it all drug-induced hepatitis?

1 reference

12 December 2020

Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.51.2.132

1 reference

14 August 2017

1 reference

14 August 2017

1 reference